FDA Inspection 1022656 — Chongqing Carelife Pharmaceutical Co., Ltd.
The FDA completed an inspection of Chongqing Carelife Pharmaceutical Co., Ltd. on Jul 26, 2017 in Chongqing. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 26, 2017
- Fiscal Year
- 2017
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Chongqing (China)